NLRP3 and cancer: On the other hand, the release of ATP from the dying cancer cells activates P2X7 purinergic receptors on DCs and triggers the secretion of interleukin-1β(IL-1) through the activation of caspase-1, which depends on NLR family pyrin domain containing 3 (NLRP3) [93].